Asahi Intecc Co., Ltd. (AHICF)
USD 16.17
(0.0%)
USD 16.17
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 22.13 Billion JPY | 22.77% |
| 2023 | 18.03 Billion JPY | 18.31% |
| 2022 | 15.23 Billion JPY | 19.1% |
| 2021 | 12.79 Billion JPY | 2.81% |
| 2020 | 12.44 Billion JPY | -17.95% |
| 2019 | 15.16 Billion JPY | 10.13% |
| 2018 | 13.77 Billion JPY | 27.59% |
| 2017 | 10.79 Billion JPY | 7.92% |
| 2016 | 10 Billion JPY | 25.4% |
| 2015 | 7.97 Billion JPY | 33.04% |
| 2014 | 5.99 Billion JPY | 37.77% |
| 2013 | 4.35 Billion JPY | -3.5% |
| 2012 | 4.5 Billion JPY | -20.5% |
| 2011 | 5.67 Billion JPY | 20.78% |
| 2010 | 4.69 Billion JPY | 48.97% |
| 2009 | 3.15 Billion JPY | 22.22% |
| 2008 | 2.57 Billion JPY | 14.09% |
| 2007 | 2.26 Billion JPY | 11.24% |
| 2006 | 2.03 Billion JPY | 32.32% |
| 2005 | 1.53 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | 2.47 Billion JPY | -59.75% |
| 2024 Q3 | 6.15 Billion JPY | 12.95% |
| 2024 Q1 | 8.04 Billion JPY | 399.07% |
| 2024 Q2 | 5.45 Billion JPY | -32.22% |
| 2023 Q2 | 5.26 Billion JPY | 12.36% |
| 2023 FY | 18.03 Billion JPY | 18.31% |
| 2023 Q4 | 1.61 Billion JPY | -75.07% |
| 2023 Q1 | 4.68 Billion JPY | 43.96% |
| 2023 Q3 | 6.46 Billion JPY | 22.83% |
| 2022 Q4 | 3.25 Billion JPY | -16.17% |
| 2022 FY | 15.23 Billion JPY | 19.1% |
| 2022 Q3 | 3.88 Billion JPY | -10.61% |
| 2022 Q2 | 4.34 Billion JPY | 15.62% |
| 2022 Q1 | 3.75 Billion JPY | 38.69% |
| 2021 Q3 | 3.9 Billion JPY | 47.06% |
| 2021 Q4 | 2.7 Billion JPY | -30.54% |
| 2021 Q2 | 2.65 Billion JPY | -24.96% |
| 2021 FY | 12.79 Billion JPY | 2.81% |
| 2021 Q1 | 3.53 Billion JPY | 4362.23% |
| 2020 FY | 12.44 Billion JPY | -17.95% |
| 2020 Q4 | 79.19 Million JPY | -97.83% |
| 2020 Q1 | 4.97 Billion JPY | 121.42% |
| 2020 Q2 | 3.72 Billion JPY | -25.1% |
| 2020 Q3 | 3.65 Billion JPY | -1.92% |
| 2019 FY | 15.16 Billion JPY | 10.13% |
| 2019 Q4 | 2.24 Billion JPY | -49.29% |
| 2019 Q3 | 4.43 Billion JPY | 18.69% |
| 2019 Q2 | 3.73 Billion JPY | -21.33% |
| 2019 Q1 | 4.74 Billion JPY | 223.96% |
| 2018 Q3 | 3.95 Billion JPY | -3.65% |
| 2018 Q2 | 4.1 Billion JPY | -3.44% |
| 2018 Q1 | 4.24 Billion JPY | 212.24% |
| 2018 Q4 | 1.46 Billion JPY | -62.92% |
| 2018 FY | 13.77 Billion JPY | 27.59% |
| 2017 Q3 | 3.54 Billion JPY | 28.12% |
| 2017 Q1 | 3.11 Billion JPY | 178.22% |
| 2017 Q4 | 1.36 Billion JPY | -61.66% |
| 2017 Q2 | 2.77 Billion JPY | -11.02% |
| 2017 FY | 10.79 Billion JPY | 7.92% |
| 2016 Q3 | 3.19 Billion JPY | 26.62% |
| 2016 Q1 | 3.16 Billion JPY | 117.7% |
| 2016 FY | 10 Billion JPY | 25.4% |
| 2016 Q4 | 1.11 Billion JPY | -64.96% |
| 2016 Q2 | 2.52 Billion JPY | -20.37% |
| 2015 Q4 | 1.45 Billion JPY | -38.71% |
| 2015 Q1 | 2.06 Billion JPY | 117.85% |
| 2015 FY | 7.97 Billion JPY | 33.04% |
| 2015 Q3 | 2.37 Billion JPY | 13.89% |
| 2015 Q2 | 2.08 Billion JPY | 1.03% |
| 2014 Q2 | 1.55 Billion JPY | -1.89% |
| 2014 Q3 | 1.91 Billion JPY | 23.09% |
| 2014 Q4 | 947.04 Million JPY | -50.47% |
| 2014 FY | 5.99 Billion JPY | 37.77% |
| 2014 Q1 | 1.58 Billion JPY | 62.91% |
| 2013 Q2 | 1.38 Billion JPY | 26.33% |
| 2013 Q3 | 1.15 Billion JPY | -17.03% |
| 2013 Q4 | 971.82 Million JPY | -15.74% |
| 2013 FY | 4.35 Billion JPY | -3.5% |
| 2013 Q1 | 1.1 Billion JPY | -56.79% |
| 2012 Q3 | 205.85 Million JPY | -71.36% |
| 2012 Q1 | 1.03 Billion JPY | -62.85% |
| 2012 Q2 | 718.8 Million JPY | -30.78% |
| 2012 FY | 4.5 Billion JPY | -20.5% |
| 2012 Q4 | 2.54 Billion JPY | 1137.04% |
| 2011 Q3 | 1.12 Billion JPY | 47.04% |
| 2011 Q1 | 978.93 Million JPY | -53.32% |
| 2011 FY | 5.67 Billion JPY | 20.78% |
| 2011 Q4 | 2.79 Billion JPY | 147.4% |
| 2011 Q2 | 768.3 Million JPY | -21.52% |
| 2010 Q3 | 988.18 Million JPY | 43.08% |
| 2010 FY | 4.69 Billion JPY | 48.97% |
| 2010 Q4 | 2.09 Billion JPY | 112.22% |
| 2010 Q1 | 889.68 Million JPY | -57.51% |
| 2010 Q2 | 690.65 Million JPY | -22.37% |
| 2009 Q1 | 369.9 Million JPY | 0.0% |
| 2009 Q4 | 2.09 Billion JPY | 236.4% |
| 2009 Q3 | 622.42 Million JPY | 845.45% |
| 2009 Q2 | 65.83 Million JPY | -82.2% |
| 2009 FY | 3.15 Billion JPY | 22.22% |
| 2008 FY | 2.57 Billion JPY | 14.09% |
| 2007 FY | 2.26 Billion JPY | 11.24% |
| 2006 FY | 2.03 Billion JPY | 32.32% |
| 2005 FY | 1.53 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -1901172.955% |
| Ansell Limited | 129.3 Million USD | -17019.103% |
| Ansell Limited | 129.3 Million USD | -17019.103% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -70986.341% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 1387264.638% |
| Psykey, Inc. | -797.5 Thousand USD | 2775634.668% |
| ConvaTec Group Plc | 262.7 Million USD | -8325.961% |
| ConvaTec Group Plc | 262.7 Million USD | -8325.961% |
| Encision Inc. | -640.78 Thousand USD | 3454467.547% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 15609013.335% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 20135640.799% |
| Innovative MedTech Inc. | -4.27 Million USD | 517989.715% |
| LifePoint, Inc. | -7.49 Million USD | 295421.236% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 341689.506% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -6707475.758% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 18012143.291% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 4737108.804% |
| SmileDirectClub, Inc. | -241.15 Million USD | 9278.706% |
| Sector 10, Inc. | -39.84 Thousand USD | 55554261.229% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | -6825.698% |
| SheerVision, Inc. | 155.72 Thousand USD | -14213968.299% |
| United Health Products, Inc. | -2.42 Million USD | 912304.584% |
| Vasamed, Inc. | 4.74 Million USD | -466656.44% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 964949.153% |
| Yubo International Biotech Limited | -1.2 Million USD | 1836689.577% |